Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 184

1.

Reducing Health Inequities in the U.S.: Recommendations From the NHLBI's Health Inequities Think Tank Meeting.

Sampson UK, Kaplan RM, Cooper RS, Diez Roux AV, Marks JS, Engelgau MM, Peprah E, Mishoe H, Boulware LE, Felix KL, Califf RM, Flack JM, Cooper LA, Gracia JN, Henderson JA, Davidson KW, Krishnan JA, Lewis TT, Sanchez E, Luban NL, Vaccarino V, Wong WF, Wright JT Jr, Meyers D, Ogedegbe OG, Presley-Cantrell L, Chambers DA, Belis D, Bennett GC, Boyington JE, Creazzo TL, de Jesus JM, Krishnamurti C, Lowden MR, Punturieri A, Shero ST, Young NS, Zou S, Mensah GA.

J Am Coll Cardiol. 2016 Aug 2;68(5):517-24. doi: 10.1016/j.jacc.2016.04.059. Review.

PMID:
27470459
2.

Do We Need a New Definition of Hypertension After SPRINT?

Schiffrin EL, Calhoun DA, Flack JM.

Am J Hypertens. 2016 Jun 22. pii: hpw068. [Epub ahead of print] No abstract available.

PMID:
27334926
3.

Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension - Insights From the SYMPLICITY HTN-3 Trial.

Kario K, Bhatt DL, Kandzari DE, Brar S, Flack JM, Gilbert C, Oparil S, Robbins M, Townsend RR, Bakris G.

Circ J. 2016 May 25;80(6):1404-12. doi: 10.1253/circj.CJ-16-0035. Epub 2016 Apr 26.

4.

A preliminary experimental examination of worldview verification, perceived racism, and stress reactivity in African Americans.

Lucas T, Lumley MA, Flack JM, Wegner R, Pierce J, Goetz S.

Health Psychol. 2016 Apr;35(4):366-75. doi: 10.1037/hea0000284.

5.

The Authors Reply, "as-needed intravenous antihypertensive therapy and blood pressure control".

Flack JM, Moser LR, Lipari M, Petrovitch E, Farber M.

J Hosp Med. 2016 Jul;11(7):526. doi: 10.1002/jhm.2565. Epub 2016 Feb 26. No abstract available.

PMID:
26918782
6.

Genetic African Ancestry and Markers of Mineral Metabolism in CKD.

Gutiérrez OM, Parsa A, Isakova T, Scialla JJ, Chen J, Flack JM, Nessel LC, Gupta J, Bellovich KA, Steigerwalt S, Sondheimer JH, Wright JT Jr, Feldman HI, Kusek JW, Lash JP, Wolf M.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):653-62. doi: 10.2215/CJN.08020715. Epub 2016 Feb 8.

PMID:
26912553
7.

Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.

Thomas G, Xie D, Chen HY, Anderson AH, Appel LJ, Bodana S, Brecklin CS, Drawz P, Flack JM, Miller ER 3rd, Steigerwalt SP, Townsend RR, Weir MR, Wright JT Jr, Rahman M; CRIC Study Investigators.

Hypertension. 2016 Feb;67(2):387-96. doi: 10.1161/HYPERTENSIONAHA.115.06487. Epub 2015 Dec 28.

PMID:
26711738
8.

A Message From the New Editorial Team at the American Journal of Hypertension.

Schiffrin EL, Calhoun DA, Flack JM, Ito S, Webb RC.

Am J Hypertens. 2016 Jan;29(1):1. doi: 10.1093/ajh/hpv173. No abstract available.

PMID:
26658829
9.

SPRINT Proves that Lower Is Better for Nondiabetic High-Risk Patients, but at a Price.

Schiffrin EL, Calhoun DA, Flack JM.

Am J Hypertens. 2016 Jan;29(1):2-4. doi: 10.1093/ajh/hpv190. Epub 2015 Nov 23. No abstract available.

PMID:
26597221
10.

As-needed intravenous antihypertensive therapy and blood pressure control.

Lipari M, Moser LR, Petrovitch EA, Farber M, Flack JM.

J Hosp Med. 2016 Mar;11(3):193-8. doi: 10.1002/jhm.2510. Epub 2015 Nov 12.

PMID:
26560085
11.

Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD.

Navaneethan SD, Roy J, Tao K, Brecklin CS, Chen J, Deo R, Flack JM, Ojo AO, Plappert TJ, Raj DS, Saydain G, Sondheimer JH, Sood R, Steigerwalt SP, Townsend RR, Dweik RA, Rahman M; Chronic Renal Insufficiency Cohort Investigators.

J Am Soc Nephrol. 2016 Mar;27(3):877-86. doi: 10.1681/ASN.2014111111. Epub 2015 Sep 18.

PMID:
26386072
12.

An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial.

Flack JM, Bhatt DL, Kandzari DE, Brown D, Brar S, Choi JW, D'Agostino R, East C, Katzen BT, Lee L, Leon MB, Mauri L, O'Neill WW, Oparil S, Rocha-Singh K, Townsend RR, Bakris G; SYMPLICITY HTN-3 Investigators.

J Am Soc Hypertens. 2015 Oct;9(10):769-79. doi: 10.1016/j.jash.2015.08.001. Epub 2015 Aug 8.

PMID:
26362830
13.

Blood pressure treatment and outcomes in hypertensive patients without acute target organ damage: a retrospective cohort.

Levy PD, Mahn JJ, Miller J, Shelby A, Brody A, Davidson R, Burla MJ, Marinica A, Carroll J, Purakal J, Flack JM, Welch RD.

Am J Emerg Med. 2015 Sep;33(9):1219-24. doi: 10.1016/j.ajem.2015.05.036. Epub 2015 May 30.

PMID:
26087706
14.

Safety and efficacy of antihypertensive prescription at emergency department discharge.

Brody A, Rahman T, Reed B, Millis S, Ference B, Flack JM, Levy PD.

Acad Emerg Med. 2015 May;22(5):632-5. doi: 10.1111/acem.12660. Epub 2015 Apr 22.

15.

12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.

Bakris GL, Townsend RR, Flack JM, Brar S, Cohen SA, D'Agostino R, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL; SYMPLICITY HTN-3 Investigators.

J Am Coll Cardiol. 2015 Apr 7;65(13):1314-21. doi: 10.1016/j.jacc.2015.01.037.

16.

Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study.

Ference BA, Majeed F, Penumetcha R, Flack JM, Brook RD.

J Am Coll Cardiol. 2015 Apr 21;65(15):1552-61. doi: 10.1016/j.jacc.2015.02.020. Epub 2015 Mar 11.

17.

Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.

Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S, O'Neill WW, Patel MR, Rocha-Singh K, Sobotka PA, Svetkey L, Townsend RR, Bakris GL.

Eur Heart J. 2015 Jan 21;36(4):219-27. doi: 10.1093/eurheartj/ehu441. Epub 2014 Nov 16.

18.

Primary care in the emergency department -- an untapped resource for public health research and innovation.

Brody AM, Murphy E, Flack JM, Levy PD.

West Indian Med J. 2014 Jun;63(3):234-7. doi: 10.7727/wimj.2013.332. Epub 2014 Jun 11.

19.

Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension.

Mahn JJ, Dubey E, Brody A, Welch R, Zalenski R, Flack JM, Ference B, Levy PD.

Acad Emerg Med. 2014 Sep;21(9):996-1002. doi: 10.1111/acem.12462.

20.

Utility of Framingham risk score in urban emergency department patients with asymptomatic hypertension.

Brody AM, Flack JM, Ference BA, Levy PD.

Crit Pathw Cardiol. 2014 Sep;13(3):114-6. doi: 10.1097/HPC.0000000000000016.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk